Zobrazeno 1 - 10
of 312
pro vyhledávání: '"5-HT1a receptor agonist"'
Autor:
Cheng, Jiaxin a, b, 1, Wu, Chunhui c, 1, Wang, Yu a, b, Wang, Zhen a, b, He, Yang a, b, ⁎, Shen, Jingshan a, b, ⁎
Publikováno v:
In Pharmacology, Biochemistry and Behavior September 2024 242
Autor:
Pereira-Sousa, Joana a, b, c, Ferreira-Lomba, Bruna a, b, Bellver-Sanchis, Aina a, b, 1, Vilasboas-Campos, Daniela a, b, Fernandes, Jorge H. a, b, Costa, Marta D. a, b, Varney, Mark A. d, Newman-Tancredi, Adrian d, Maciel, Patrícia a, b, ⁎, 2, Teixeira-Castro, Andreia a, b, ⁎, 2
Publikováno v:
In Neurobiology of Disease May 2021 152
Publikováno v:
In Experimental Neurology October 2020 332
Autor:
Franchini, Silvia a, ∗∗, Sorbi, Claudia a, Linciano, Pasquale a, Carnevale, Gianluca b, Tait, Annalisa a, Ronsisvalle, Simone c, Buccioni, Michela d, Del Bello, Fabio d, Cilia, Antonio e, Pirona, Lorenza e, Denora, Nunzio f, Iacobazzi, Rosa Maria g, Brasili, Livio a, ∗
Publikováno v:
In European Journal of Medicinal Chemistry 15 August 2019 176:310-325
Autor:
Joana Pereira-Sousa, Bruna Ferreira-Lomba, Aina Bellver-Sanchis, Daniela Vilasboas-Campos, Jorge H. Fernandes, Marta D. Costa, Mark A. Varney, Adrian Newman-Tancredi, Patrícia Maciel, Andreia Teixeira-Castro
Publikováno v:
Neurobiology of Disease, Vol 152, Iss , Pp 105278- (2021)
Machado-Joseph disease (MJD) or Spinocerebellar ataxia type 3 (SCA3) is a progressive neurodegenerative disorder that affects movement coordination leading to a premature death. Despite several efforts, no disease-modifying treatment is yet available
Externí odkaz:
https://doaj.org/article/e41189f9afdf44e5bfd5004837e21f7b
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yann Develle, Hugues Leblond
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 13 (2020)
Pharmacological treatment facilitating locomotor expression will also have some effects on reflex expression through the modulation of spinal circuitry. Buspirone, a partial serotonin receptor agonist (5-HT1A), was recently shown to facilitate and ev
Externí odkaz:
https://doaj.org/article/31318f81c6604c21b7a0d1f49a378944
Publikováno v:
Molecules, Vol 25, Iss 21, p 5078 (2020)
Depression is a severe psychiatric disorder that affects over 100 million people worldwide. 5-HT1A receptor agonists have been implicated in the treatment of a variety of central nervous system diseases, especially depression. In this study, based on
Externí odkaz:
https://doaj.org/article/f38199c7a6cb456baca1c337131dc1fe
Autor:
Partyka, Anna a, ⁎, Chłoń-Rzepa, Grażyna b, †, Wasik, Anna a, ‡, Jastrzębska-Więsek, Magdalena a, ‡, Bucki, Adam b, §, Kołaczkowski, Marcin b, §, Satała, Grzegorz c, ¶, Bojarski, Andrzej J. c, ¶, Wesołowska, Anna a, ‡
Publikováno v:
In Bioorganic & Medicinal Chemistry 1 January 2015 23(1):212-221
Publikováno v:
In European Journal of Pharmacology 5 March 2013 703(1-3):33-41